06.27.2018
Research Networks
$1,612,740.00
36 months
Defining and Developing the Therapeutic Pipeline for VEO-IBD: Toronto Studies
The lack of standard of care in evaluation and treatment of VEO-IBD has hindered the accelerated development of personalized therapeutics for these patients. This study proposes to further establish and disseminate a standard of care model tailored to meet the needs of VEO-IBD by studying the molecular causes of VEO-IBD.